Literature DB >> 9440134

Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype.

K Nemoto1, C C Pilbeam, S R Bilak, L G Raisz.   

Abstract

Prostaglandin E2 (PGE2) is a potent local mediator of cell growth and differentiation in various tissues. The receptors for PGE2 have been classified into four pharmacological subtypes, EP1, EP2, EP3, and EP4, based on the responses to selective agonists and antagonists. We have cloned a functional cDNA for the rat EP2 receptor subtype from a rat lung cDNA library. The rat EP2 receptor cDNA encodes 357 amino acid residues having high homology with the human and mouse EP2 receptors and containing seven putative transmembrane domains. In COS-7 cells transfected with rat EP2 cDNA, specific [3H]PGE2 binding was found with a dissociation constant of 14.9 nM, and this binding was inhibited by unlabeled PGE2 and PGE2 alpha. PGE2 and butaprost, an EP2 selective agonist, were effective in increasing the cAMP level in the COS-7 cell transfectants. Northern blot and RT-PCR analysis showed widespread distribution of the EP2 receptor in various tissues. Higher EP2 expression was found in fetal long bones and calvariae than in adult by RT-PCR and in situ hybridization, suggesting a role for this receptor in rapidly growing skeletal tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440134     DOI: 10.1016/s0090-6980(97)00145-7

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

Review 1.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

2.  Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis.

Authors:  Y Kurihara; H Endo; T Akahoshi; H Kondo
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor.

Authors:  S L Tilley; L P Audoly; E H Hicks; H S Kim; P J Flannery; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

4.  Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.

Authors:  Shigeki Koide; Yoshimasa Kobayashi; Yutaka Oki; Hirotoshi Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

5.  Adenosine 3', 5' cyclic monophosphate attenuates the production of fibronectin in the glomeruli of anti-glomerular basement membrane antibody-associated nephritic rats.

Authors:  Tadashi Nagamatsu; Tsutomu Nishiyama; Isamu Goto; Toshiyuki Nagao; Yoshio Suzuki
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

6.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

7.  Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor.

Authors:  Y Guan; Y Zhang; R M Breyer; B Fowler; L Davis; R L Hébert; M D Breyer
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

8.  Inflammatory Profile and Osteogenic Potential of Fracture Haematoma in Humans.

Authors:  Ippokratis Pountos; Gavin Walters; Michalis Panteli; Thomas A Einhorn; Peter V Giannoudis
Journal:  J Clin Med       Date:  2019-12-24       Impact factor: 4.241

9.  Effect of PGE2-EPs pathway on primary cultured rat neuron injury caused by aluminum.

Authors:  Lu Yang; Yuling Wei; Ying Luo; Qunfang Yang; Huan Li; Congli Hu; Yang Yang; Junqing Yang
Journal:  Oncotarget       Date:  2017-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.